Breastfeeding While Taking MS Monoclonal Antibody Drugs Appears Safe
No negative effects on early infant development or health seen
Stay updated with breaking news from German Multiple Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
No negative effects on early infant development or health seen
A summary of research findings on multiple sclerosis diagnosis and treatment from ACTRIMS Forum 2023.
Two studies report few complications from continuing ocrelizumab and natalizumab into pregnancy, with high live birth rates, a decline in elective abortions, and few major congenital abnormalities in newborns.
Final safety and efficacy results from the Phase 3 EVOLVE-MS-1 trial demonstrate decreases in disease activity and favorable tolerability for VUMERITY (diroximel fumarate) consistent with previous
Change to COPAXONE(Glatiramer Acetate (GA)) Summary of Product Characteristics (SmPC) in breastfeeding is relevant for the Multiple Sclerosis ("MS") community and provides information for neurologists